161 related articles for article (PubMed ID: 35283533)
1. A Prospective Study Examining the Effect of Selected Topical and Systemic Drugs on Pruritus Grading System Score and STAT 6 Expression in Patients of Prurigo Nodularis.
Agrawal D; Sardana K; Mathachan SR; Bhardwaj M; Ahuja A; Jain S
Indian J Dermatol; 2021; 66(6):638-644. PubMed ID: 35283533
[TBL] [Abstract][Full Text] [Related]
2. A prospective study examining the expression of STAT 1, 3, 6 in prurigo nodularis lesions with its immunopathogenic and therapeutic implications.
Agrawal D; Sardana K; Mathachan SR; Bhardwaj M; Ahuja A; Jain S
J Cosmet Dermatol; 2022 Sep; 21(9):4009-4015. PubMed ID: 34965028
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide for the treatment of chronic refractory prurigo nodularis.
Aguh C; Kwatra SG; He A; Okoye GA
Dermatol Online J; 2018 Mar; 24(3):. PubMed ID: 29634881
[TBL] [Abstract][Full Text] [Related]
4. Prurigo nodularis: a review.
Lee MR; Shumack S
Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418
[TBL] [Abstract][Full Text] [Related]
5. Treatment-resistant prurigo nodularis: challenges and solutions.
Kowalski EH; Kneiber D; Valdebran M; Patel U; Amber KT
Clin Cosmet Investig Dermatol; 2019; 12():163-172. PubMed ID: 30881076
[TBL] [Abstract][Full Text] [Related]
6. Oral ketotifen and topical antibiotic therapy in the management of pruritus in prurigo nodularis: a randomized, controlled, single-blind, parallel study.
Sharma AD
Indian J Dermatol; 2013 Sep; 58(5):355-9. PubMed ID: 24082179
[TBL] [Abstract][Full Text] [Related]
7. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need.
Pereira MP; Basta S; Moore J; Ständer S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2224-2229. PubMed ID: 29869425
[TBL] [Abstract][Full Text] [Related]
8. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
[TBL] [Abstract][Full Text] [Related]
9. Treatment of prurigo nodularis with lenalidomide.
Ossorio-García L; Jiménez-Gallo D; Rodríguez-Mateos ME; Arjona-Aguilera C; Linares-Barrios M
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27891738
[TBL] [Abstract][Full Text] [Related]
10. A Review of the Efficacy of Thalidomide and Lenalidomide in the Treatment of Refractory Prurigo Nodularis.
Lim VM; Maranda EL; Patel V; Simmons BJ; Jimenez JJ
Dermatol Ther (Heidelb); 2016 Sep; 6(3):397-411. PubMed ID: 27289372
[TBL] [Abstract][Full Text] [Related]
11. Prurigo nodularis: retrospective study of 13 cases managed with methotrexate.
Spring P; Gschwind I; Gilliet M
Clin Exp Dermatol; 2014 Jun; 39(4):468-73. PubMed ID: 24825138
[TBL] [Abstract][Full Text] [Related]
12. Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus.
Elmariah S; Kim B; Berger T; Chisolm S; Kwatra SG; Mollanazar N; Yosipovitch G
J Am Acad Dermatol; 2021 Mar; 84(3):747-760. PubMed ID: 32682025
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide for the treatment of chronic refractory pruritus.
Sharma D; Kwatra SG
J Am Acad Dermatol; 2016 Feb; 74(2):363-9. PubMed ID: 26577510
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Treatment Outcomes of Prurigo Nodularis: A Retrospective Study.
Taghaddos D; Savinova I; Abu-Hilal M
J Cutan Med Surg; 2024; 28(2):141-145. PubMed ID: 38281092
[TBL] [Abstract][Full Text] [Related]
15. Non-Systemic Medication for the Treatment of Prurigo Nodularis: A Systematic Review.
Ranpariya M; Zaino ML; McCampbell LE; Patel T; Feldman SR
J Cutan Med Surg; 2024; 28(2):173-177. PubMed ID: 38291823
[TBL] [Abstract][Full Text] [Related]
16. Prurigo Nodularis Management.
Tsianakas A; Zeidler C; Ständer S
Curr Probl Dermatol; 2016; 50():94-101. PubMed ID: 27578077
[TBL] [Abstract][Full Text] [Related]
17. Prurigo Nodularis and Its Management.
Zeidler C; Yosipovitch G; Ständer S
Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
[TBL] [Abstract][Full Text] [Related]
18. INDIVIDUAL ARTICLE: Management of Prurigo Nodularis.
Elmariah SB; Tao L; Valdes-Rodriguez R; Laquer V
J Drugs Dermatol; 2023 Dec; 22(12):SF365502s15-SF365502s22. PubMed ID: 38051855
[TBL] [Abstract][Full Text] [Related]
19. Prurigo nodularis of Hyde treated with low-dose thalidomide.
Orlando A; Renna S; Cottone M
Eur Rev Med Pharmacol Sci; 2009; 13(2):141-5. PubMed ID: 19499850
[TBL] [Abstract][Full Text] [Related]
20. Abnormal Plasma Levels of Steroids and Their Ratios in Patients With Prurigo Nodularis: A Pilot Study.
Chu L; Shu X; Wu Y; Yang H; Lu Q; Deng H
Front Physiol; 2022; 13():835269. PubMed ID: 35837010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
